دورية أكاديمية
أعرض في EDS

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope

التفاصيل البيبلوغرافية
العنوان: Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
المؤلفون: Md Yusof, Md Yuzaiful, Smith, Eve MD, Ainsworth, Sammy, Armon, Kate, Beresford, Michael W, Brown, Morgan, Cherry, Lindsey, Edwards, Christopher J, Flora, Kalveer, Gilman, Rebecca, Griffiths, Bridget, Gordon, Caroline, Howard, Paul, Isenberg, David, Jordan, Natasha, Kaul, Arvind, Lanyon, Peter, Laws, Philip M, Lightsone, Liz, Lythgoe, Hanna, Mallen, Christian D, Marks, Stephen D, Maxwell, Naomi, Moraitis, Elena, Nash, Clare, Pepper, Ruth J, Pilkington, Clarissa, Psarras, Antonios, Rostron, Heather, Skeates, Jade, Skeoch, Sarah, Tremarias, Dalila, Wincup, Chris, Zoma, Asad, Vital, Edward M
بيانات النشر: //dx.doi.org/10.1093/rap/rkad093
Rheumatology Advances in Practice
Oxford University Press (OUP)
سنة النشر: 2023
المجموعة: Apollo - University of Cambridge Repository
مصطلحات موضوعية: management, systemic lupus erythematosus, guideline, lupus nephritis, biologic DMARDs
الوصف: Funder: British Society for Rheumatology; DOI: https://doi.org/10.13039/501100000568Test ; Abstract The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in ‘Creating Clinical Guidelines: Our Protocol’ by the British Society for Rheumatology.
نوع الوثيقة: article in journal/newspaper
وصف الملف: text/xml; application/pdf; application/zip
اللغة: English
العلاقة: https://www.repository.cam.ac.uk/handle/1810/361907Test
الإتاحة: https://www.repository.cam.ac.uk/handle/1810/361907Test
رقم الانضمام: edsbas.7D708580
قاعدة البيانات: BASE
الوصف
الوصف غير متاح.